Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Alto Neuroscience, Inc.Alto Neuroscience Reports $27.6 Million Net Loss and Increased R&D Expenses in Latest 10-Q
Enovix CorpEnovix Corporation Reports 21% Revenue Growth to $9.0 Million, Net Loss of $43.1 Million for Quarter Ending July 5, 2026
QUICKLOGIC CorpQuickLogic Reports 49% Revenue Growth to $5.5 Million in Q2 2026
ACP Holdings Acquisition Corp.ACP Holdings Reports Net Income of $1.17M for Quarter Ending June 30, 2026
First Tracks Biotherapeutics, Inc.First Tracks Biotherapeutics Reports $33.4 Million Net Loss in Q2 2026, Decreased from Previous Year
FIRST COMMUNITY CORP /SC/First Community Corporation Reports 46% Increase in Net Income to $7.6 Million
Armata Pharmaceuticals, Inc.Armata Pharmaceuticals Reports 15.7% Revenue Growth and $74.1 Million Net Income in Q2 2026
United Acquisition Corp. IUnited Acquisition Corp. I Reports Net Income of $691,371 for Quarter Ending June 30, 2026
ERock, Inc.ERock Reports 41.7% Revenue Decline and $67.7 Million Net Loss in Latest Quarter
Andersen Group Inc.Andersen Group Inc. Reports 23.7% Revenue Growth to $217.7 Million in Latest Quarter
Lulu's Fashion Lounge Holdings, Inc.Lulu's Fashion Lounge Reports 17% Revenue Decline in Q2 Fiscal 2026
M.D.C. HOLDINGS, INC.Sekisui House Reports 49% Decline in Net Income for Q2 2026
InPoint Commercial Real Estate Income, Inc.InPoint Commercial Real Estate Reports $3.98 Million Net Loss for Q2 2026
Research Alliance Corp IIIResearch Alliance Corporation III Reports Net Income of $54,050 for Quarter Ending June 30, 2026
ONCOLYTICS BIOTECH INCOncolytics Biotech Reports $9.4 Million Net Loss in Q2 2026, Seeks Additional Financing
Atara Biotherapeutics, Inc.Atara Biotherapeutics Reports 96% Revenue Decline and Organizational Restructuring
Sunshine Silver Mining & Refining CoSunshine Silver Mining Reports $16.7M Net Loss in Latest Quarter, IPO Boosts Assets
Allogene Therapeutics, Inc.Allogene Therapeutics Reports $42.7 Million Net Loss in Q2 2026, Improved Financial Metrics
NOBLE ROMANS INCNoble Roman's Reports Q2 2026 Revenue of $4.12 Million, Net Income Decline
MIRA PHARMACEUTICALS, INC.Mira Pharmaceuticals Reports $1.2 Million Net Loss in Q2 2026, Focuses on R&D
JACK IN THE BOX INCJack in the Box Reports Decrease in Revenue and Earnings for Quarter Ending July 5, 2026
ITG, Inc./DE/ITG, Inc. Reports 38.4% Revenue Growth but Significant Net Loss in Latest 10-Q Filing
Connect Biopharma Holdings LtdConnect Biopharma Reports Significant Revenue Increase and Expanded Clinical Programs in Q2 2026
EnerSysEnerSys Reports 4.8% Net Sales Increase to $935.6 Million in Q1 Fiscal 2027
WILLAMETTE VALLEY VINEYARDS INCWillamette Valley Vineyards Reports Decline in Q2 Net Sales and Increased Losses for 2026